This reply is not directed at either of you. Just

This reply is not directed at either of you. Just chiming in on this thread ...

Investors seem to fall into two camps. One camp blames management. One camp blames FDA, BP, and others.

We need to remember that the two issues are not mutually exclusive.

It is possible (IMO, nearly certain) that CYDY has faced unreasonable hurdles from the FDA and interference from BP/others and, at the same time, that CYDY management has committed unforced errors, likely due to inexperience and learning on the job, that have lengthened the process with the FDA and/or made it much easier for BP and other forces to work to the company's detriment.

In my opinion, it is not the fault of CYDY management that the path forward is difficult due to reasons beyond their control, but it is the fault of CYDY management if they fail to recognize those difficulties and fail to hire and RETAIN talented subject matter experts to smooth the way.

And it's the latter point with which I and other long-term investors, who have watched this story for years upon years, have reached a point of frustration.